Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer

Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer

Accumulating evidence demonstrates important roles for histone deacetylase in tumorigenesis (HDACs), highlighting them as attractive targets for antitumor drug development. Histone deactylase inhibitors (HDACIs), which have shown favorable anti-tumor activity with low toxicity in clinical investigat...

Full description

Bibliographic Details
Main Authors: Tao Zhang, Yihua Chen, Jingjie Li, Feifei Yang, Haigang Wu, Fujun Dai, Meichun Hu, Xiaoling Lu, Yi Peng, Mingyao Liu, Yongxiang Zhao, Zhengfang Yi
Format: Article
Language:English
Published: Elsevier 2014-08-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558614001031

Internet

http://www.sciencedirect.com/science/article/pii/S1476558614001031

Similar Items